Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts.
Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts.
复制标题
DOI:
10.1161/circresaha.111.247957
复制
发表时间:
2011-09-16
影响因子:
20.1
通讯作者:
Pitt GS
中科院分区:
文献类型:
--
作者:
Wang C;Hennessey JA;Kirkton RD;Wang C;Graham V;Puranam RS;Rosenberg PB;Bursac N;Pitt GS
Fibroblast growth factor homologous factors (FHFs), a subfamily of fibroblast growth factors (FGFs) that are incapable of functioning as growth factors, are intracellular modulators of Na+ channels and have been linked to neurodegenerative diseases. Although certain FHFs have been found in embryonic heart, they have not been reported in adult heart, and they have not been shown to regulate endogenous cardiac Na+ channels nor participate in cardiac pathophysiology. We tested whether FHFs regulate Na+ channels in murine heart. We demonstrated that isoforms of FGF13 are the predominant FHFs in adult mouse ventricular myocytes. FGF13 binds directly to, and co-localizes with the Na 1.5 Na+ V channel in the sarcolemma of adult mouse ventricular myocytes. Knockdown of FGF13 in adult mouse ventricular myocytes revealed a loss-of-function of NaV1.5: reduced Na+ current (INa) density, decreased Na+ channel availability, and slowed INa recovery from inactivation. Cell surface biotinylation experiments showed a ~45% reduction in NaV1.5 protein at the sarcolemma after FGF13 knockdown, whereas no changes in whole-cell NaV1.5 protein nor mRNA level were observed. Optical imaging in neonatal rat ventricular myocyte monolayers demonstrated slowed conduction velocity and a reduced maximum capture rate after FGF13 knockdown. These findings show that FHFs are potent regulators of Na+ channels in adult ventricular myocytes and suggest that loss-of-function mutations in FHFs may underlie a similar set of cardiac arrhythmias and cardiomyopathies that result from NaV1.5 loss-of-function mutations.